Malaysian Association of Pharmaceutical Suppliers (MAPS)
President's Message - December 2020
We are now in December 2020, the last month of 2020! The journey of the past months has not been easy. Malaysia and the World were in different stages of “lock-down” of the economy as Covid-19 continues to wreak havoc on the world stage. It was a Pandemic that was unprecedented. We were all, and still are, learning how best to manage the economy and the health and life of the populations.
As we enter the year 2021, there is a renewed hope as Pfizer’s Covid-19 vaccines had just been approved for use by Countries like the MHRA of the UK and US FDA. Many more Covid-19 vaccines are also in the final stages of Phase 3 Clinical trials and are also near completion and ready for regulatory approvals as well. Malaysia is also entering a Phase 3 Clinical trial for Sinopharm Covid-19 vaccine as well as Pfizer’s Covid-19 vaccine is pending regulatory approval for registration by the NPRA.
Thus 2021 promises a better year for the economy. In a World Bank Report on 17th December 2020, the headline read as “Despite rising fiscal deficit and government debt in 2020, Malaysia’s economy is forecast to grow by 6.7% in 2021” This is also aligned with the Country’s Budget 2021 forecast at 6.0% compared with an estimated contraction of 5.8% this year.
From the recent “MCO & Covid-19 - Business Impact and Brief Salary Survey, 2020” conducted by MAPS, members were negatively affected in Revenues and Profits. However, none resorted to drastic measures like staff reduction though actions were taken to manage costs and expenses. Responders expressed that while businesses will face more difficulties in operation, there is cautious confidence for a better 2021 albeit a need to adopt new approaches and strategies in a post Covid-19 market landscape. The Survey Committee has also proposed a series of approaches and tools to be considered by the Company in the Survey Report.
MAPS’ Secretariat has also been engaging members during the various stages of MCO period. We are glad that the Secretariat was able to take the lead during the earlier part of the MCO. Members were kept abreast with information and advice as the Government introduced strict Movement Control. In the past 2 weeks alone, the Pharmacy services has engaged MAPS three times in the National Medicine Policy (DUNas) on the componenents, Good Governance in Medicine, Access to Medicine and Public-Private Partnership.
The BOD was also kept busy with engagements with various stakeholders like the MITI, NPRA, PhAMA and MOPI on Industry issues. Some of these meetings were captured on MAPS’ website, which please access.
The membership renewal has been sent out, and we thank you in advance for your renewal. A stong assoication is needed to better represent our interests to the various stakeholders, eg the government, the market, etc.
In closing, on behalf of the Board of Directors, I would like to wish our Christian friends “Blessed Christmas” and also “A Better, Happy and Successful New Year, 2021” to ALL!
LIM TENG CHYUAN
Also on this page: links for Membership Application Form, Code of Conduct, Membership list, Member login
If you would like to read previous messages by the President, please visit our archive (click this)
Foreword by the PresidentI am delighted to welcome you to the MAPS website and I hope you will find the information provided here to be useful for the pharmaceutical industry in Malaysia.
I welcome participation from members to be active in subcommittees that have been formed in order to make MAPS an association where everyone can openly suggest, exchange ideas, share issues and values of common interests. Membership of MAPS is open to any company involved in pharmaceutical trade (importer and / or distributor) in Malaysia.
I look forward to warmly welcome you into MAPS.
Why we exist
The first gathering of “like-minded” interest Group for the formation of the “Malaysian Association of Pharmaceutical Suppliers (MAPS)” was on 17th March 2011 held in the premise of Medispec, Taman Mayang, Petaling Jaya.
MAPS was formally registered with the Registrar of Society on the 17th November 2011.
It was formed to fill in the "missing piece" in the trade representation in the Pharmaceutical Industry.
MAPS is having representations and engaging with the relevant Government bodies like the Bahagian Farmasi, BPFK, PEMANDU, MyCC, etc, on issues relating to the pharmaceutical trade.
MAPS is in the forefront of issues facing the Industry which means that the voices and interests of MAPS will be heard and considered. Thus, MAPS will have the opportunity to continuously collaborate and consult on the policies and regulations affecting the industry.
Board of Directors
Lim Teng Chyuan
Heng Thin Fook
Choe Tong Seng
Yeo Ann Chin
Choe Tong Seng
Board of Directors of former terms
If your company qualifies to be a member, and in concurrence with our goals, please apply for membership. Click here for the membership form.
Technical Working Groups/ External committees
MAPS practises a high ethical code. Members are required to abide by this conduct to ensure that the industry maintains a high level of integrity. Click here for MAPS' code of conduct.
Members of MAPS are Malaysian Companies which import pharmaceuticals into the country. They represent principals from Europe, North America, Asia, Oceania etc. The principals may be R&D or generic manufacturers from these regions.
|Ethics||Lim Teng Chyuan||Somedico|
|Regulatory||Yeo Ann Chin||Pharmaforte|
|Social & Sports||Mathew John||Jetpharma|
|Trade Practices||Heng Thin Fook||Medispec|
As an association, MAPS is committed to build the industry together with the respective government authorities and the industry stakeholders. The country has to have an industry that is conducive to attract investments with an ecosystem of "fairness, healthy, vibrancy, dynamic, skill and knowledgeable" and "an equitable, accessible and affordable healthcare for the rakyat in the country".
Click on this to view the membership list.
Click here to enter the members-only pages.